Oragenics (OGEN) Operating Expenses (2010 - 2026)
Oragenics' (OGEN) quarterly Operating Expenses came in at $2.3 million in Q1 2026, up 11.34% YoY from $2.0 million in Q1 2025, and down 9.7% on a QoQ basis from $2.5 million in Q4 2025.
Oragenics (OGEN) Operating Expenses (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Operating Expenses data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Operating Expenses rose 11.34% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (down 5.26% YoY) and the FY2025 annual result came in at $9.4 million, down 11.33% from the prior year.
- Operating Expenses eased to $2.3 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $12.8 million in Q4 2023 to a low of $1.7 million in Q2 2025.
- A 5-year average of $3.4 million and a median of $2.5 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses soared 456.56% — and 2024, when it slumped 73.78%.
- Tracing OGEN's Operating Expenses over 5 years: stood at $2.3 million in 2022, then soared by 456.56% to $12.8 million in 2023, then tumbled by 73.78% to $3.4 million in 2024, then dropped by 25.54% to $2.5 million in 2025, then dropped by 9.7% to $2.3 million in 2026.
- The last three Operating Expenses figures came in at $2.3 million (Q1 2026), $2.5 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 3.36 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 12.80 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 2.92 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 3.99 Mn |
| Jun 30, 2022 | 3.63 Mn |
| Mar 31, 2022 | 4.63 Mn |
| Dec 31, 2021 | 2.39 Mn |
| Sep 30, 2021 | 4.39 Mn |